MYTH 3: MARIJUANA AS HARMFUL
“Smoking is the way most cannabis users first experience the plant. About 60-65% of MMJ dispensary sales are smokables. Recreational stores, on the other hand, have reported that their customers are enthralled with infused products, such as edibles, and depending on location these products can be 60% or more of sales.” (Marijuana Business Factbook 2015. Rhode Island: Anne Holland Ventures, Inc., 2015. (page 130)).
Death Toll. “Tobacco use is considered the leading preventable cause of death in the U.S. and chronic alcohol use has been linked to everything from heart disease to cancer. According to the CDC, 1 in 10 deaths among working-age adults can be attributed to excessive alcohol use and alcohol poisonings account for more than 2,000 American deaths every year. Meanwhile, most experts say there has never been a documented overdose death from marijuana use in someone without an underlying condition.” (Shapiro, Maren. “No High Risk: Marijuana May be Less Harmful Than, Alcohol, Tobacco.” NBCNews.com. RSS N.p., 26 Feb. 2015. Web. 28. Jan. 2016).
Effects on Lungs. “Current knowledge does not suggest that cannabis smoke will have a carcinogenic potential comparable to that resulting from exposure to tobacco smoke. It should be noted that with the development of vaporizers, that use the respiratory route for the delivery of carcinogen-free cannabis vapors, the carcinogenic potential of smoked cannabis has been largely eliminated.” (Melamed, Robert. “Cannabis and tobacco smoke are not equally carcinogenic.” PubMed.Gov – US National Library of Medicine National Institutes of Health. RSS N.p. 25. Jan. 2011. Web. 28 Jan. 2016. http://www.ncbi.nlm.nih.gov/pubmed/20829306).
Mental. “Animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. These results suggest that CBD reduces anxiety in SAD and that this is related to its effects on activity in limbic and paralimbic brain areas.” (Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.” PubMed.Gov – US National Library of Medicine National Institutes of Health. RSS N.p. 25. Jan. 2011. Web. 28 Jan. 2016. http://www.ncbi.nlm.nih.gov/pubmed/20829306).
- “Anxiety and depression are pathologies that affect human beings in many aspects of life, including social life, productivity and health. Cannabidiol (CBD) is a constitutent non-psychotomimetic of Cannabis sativa with great psychiatric potential, including uses as an antidepressant-like and anxiolytic-like compound.” (“Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa.” PubMed.Gov – US National Library of Medicine National Institutes of Health. RSS N.p. 25. Jan. 2011. Web. 28 Jan. 2016. http://www.ncbi.nlm.nih.gov/pubmed/24923339).